A detailed history of Schechter Investment Advisors, LLC transactions in Organon & Co. stock. As of the latest transaction made, Schechter Investment Advisors, LLC holds 25,867 shares of OGN stock, worth $377,140. This represents 0.05% of its overall portfolio holdings.

Number of Shares
25,867
Previous 25,792 0.29%
Holding current value
$377,140
Previous $533,000 7.32%
% of portfolio
0.05%
Previous 0.05%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$18.65 - $23.03 $1,398 - $1,727
75 Added 0.29%
25,867 $494,000
Q2 2024

Aug 12, 2024

SELL
$17.45 - $21.96 $4,868 - $6,126
-279 Reduced 1.07%
25,792 $533,000
Q1 2024

May 06, 2024

SELL
$13.78 - $18.8 $3,334 - $4,549
-242 Reduced 0.92%
26,071 $490,000
Q4 2023

Jan 17, 2024

SELL
$10.95 - $17.32 $8,946 - $14,150
-817 Reduced 3.01%
26,313 $379,000
Q3 2023

Nov 06, 2023

BUY
$16.59 - $23.77 $10,501 - $15,046
633 Added 2.39%
27,130 $470,000
Q2 2023

Jul 26, 2023

BUY
$19.27 - $24.63 $111,496 - $142,509
5,786 Added 27.94%
26,497 $551,000
Q1 2023

Apr 28, 2023

SELL
$21.42 - $32.08 $7,004 - $10,490
-327 Reduced 1.55%
20,711 $487,000
Q4 2022

Feb 13, 2023

BUY
$23.31 - $28.61 $1,305 - $1,602
56 Added 0.27%
21,038 $587,000
Q3 2022

Nov 04, 2022

BUY
$23.4 - $34.25 $109,769 - $160,666
4,691 Added 28.8%
20,982 $491,000
Q2 2022

Nov 03, 2022

BUY
$31.66 - $38.9 $515,773 - $633,719
16,291 New
16,291 $549,000
Q1 2022

Nov 18, 2022

SELL
$30.45 - $39.36 $184,527 - $238,521
-6,060 Reduced 28.88%
14,922 $521,000
Q4 2021

Dec 27, 2022

SELL
$28.67 - $37.13 $171,274 - $221,814
-5,974 Reduced 28.47%
15,008 $457,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.71B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Schechter Investment Advisors, LLC Portfolio

Follow Schechter Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schechter Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schechter Investment Advisors, LLC with notifications on news.